Solid Biosciences Inc. Com NewSLDB

13F holders, Q4 2024 (December 31)
1holders
0new positions
0sold out
$4.00avg. 13F price*

At the end of Q4 2024, 1 institutions reported holding Solid Biosciences Inc. Com New (SLDB) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Parallel Advisors, LLC ($28).

Company
Solid Biosciences Inc. Com New
CUSIP
83422E105
Latest filing quarter
Q1 2026

History

Number of 13F holders

02468 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 3Q1 2025Q2 2025: 4Q2 2025Q3 2025: 5Q3 2025Q4 2025: 5Q4 2025Q1 2026: 7Q1 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Parallel Advisors, LLC 0.00% No change 7 $28

"% of holder's portfolio" is SLDB's weight in each manager's 13F, not the share of Solid Biosciences Inc. Com New the manager owns.